Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of recurrent gestational diabetes
ACTRN12610000157077Phase 4Not yet recruiting
- Sponsor
- Women's and Children's Hospital
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in gestational diabetes mellitus (GDM) comparing Metformin XR with Placebo (2 arms). Primary endpoint: Diagnosis of recurrent gestational diabetes. Planned start Mar 2010; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on ACTRN12610000157077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000157077.